The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
106 - If the US indication is the same as the Canadian one, but the US Product Monograph is more comprehensive can it be cited instead?
-
PAAB Code section 3.1 states that all claims must be consistent with, and within the limitations of, the Health Canada approved Terms of Market Authorization (TMA) (e.g. product monograph). The US FDA approved Product Monograph would not meet that requirement even if the product's indication is similar in Canada. Question #56 may also be of interest as it is similar to this current question.
